• Home
  • Contact
  • My account
  • Home
  • Contact
  • My account
Facebook Linkedin Pinterest X-twitter Youtube Instagram
Dysphagia Cafe Logo
  • Education Webinars
  • Blog
    • Acute Care
    • Advocacy
    • Anatomy
    • Art & Science
    • Coffee Break
    • Case Studies
    • Continuing Education
    • Esophageal Dysphagia
    • Evidence Based Practice
    • Reflux
    • Head Neck Cancer
    • Instrumental Assessment
    • International
    • Neurogenic Dysphagia
    • Pediatric
    • Podcasts
    • Rehabilitation
    • Telepractice
    • Webinars
  • Resources
  • About

Type To Search

No products in the cart.

Login
logotype
  • Home
  • Education Webinars
  • Blog
    • Acute Care
    • Advocacy
    • Anatomy
    • Art & Science
    • Coffee Break
    • Case Studies
    • Continuing Education
    • Esophageal Dysphagia
    • Evidence Based Practice
    • Reflux
    • Head Neck Cancer
    • Instrumental Assessment
    • International
    • Neurogenic Dysphagia
    • Pediatric
    • Podcasts
    • Rehabilitation
    • Telepractice
    • Webinars
  • Resources
Login
logotype
  • Home
  • Education Webinars
  • Blog
    • Acute Care
    • Advocacy
    • Anatomy
    • Art & Science
    • Coffee Break
    • Case Studies
    • Continuing Education
    • Esophageal Dysphagia
    • Evidence Based Practice
    • Reflux
    • Head Neck Cancer
    • Instrumental Assessment
    • International
    • Neurogenic Dysphagia
    • Pediatric
    • Podcasts
    • Rehabilitation
    • Telepractice
    • Webinars
  • Resources
  • My Courses
  • About
  • Contact
  • Disclaimer
  • My account
Facebook Linkedin Pinterest X-twitter Youtube
Utilizing Fiberoptic Endoscopic Evaluation of Swallowing (FEES®) with the Passy Muir Valve to Facilitate Successful Decannulation

Utilizing Fiberoptic Endoscopic Evaluation of Swallowing (FEES®) with the Passy Muir Valve to Facilitate Successful Decannulation

Instrumental AssessmentKristin King, PhD, CCC-SLPJuly 4, 2023

This content is sponsored by Passy-Muir

Decannulation, the removal of a tracheostomy tube, is a significant milestone in the care of patients with tracheostomies (Christiansen et al., 2022). It represents the restoration of a more natural airway and signifies improved respiratory function. However, correlations between swallowing and decannulation have been investigated. Escudero et al. (2022) found that poor swallowing function was negatively associated with successful decannulation. Therefore, decannulation often involves careful assessment and management of swallowing function to ensure safety and successful transition to oral feeding while also addressing decannulation (Escudero et al., 2022).  In patients with tracheostomy, the additional issue of having an open system with reduced pressures and decreased use of the upper airway further complicates the decannulation process. Using a Passy Muir® Tracheostomy & Ventilator Swallowing and Speaking Valve (PMV®) to close the system also has been shown to assist with decannulation (Zhou et al., 2022, O’Connor et al., 2019).  By combining these two techniques, FEES and PMV use, healthcare professionals can effectively evaluate and manage swallowing function, while facilitating safe and successful decannulation.

Understanding FEES

Fiberoptic Endoscopic Evaluation of Swallowing (FEES) is a procedure that utilizes a flexible endoscope to visualize the pharynx and larynx during swallowing. During FEES, the endoscope is passed through the nasal cavity to the pharynx, providing real-time visualization of the swallowing process. This procedure allows for the assessment of anatomical and physiological aspects of swallowing, including timing, coordination, and presence of aspiration or penetration. During a FEES assessment, it also is possible for the clinician to view secretions in the upper airway and supraglottic region, along with viewing the state of the vocal folds (Starmer, 2022).

Benefits of Combining FEES and the Passy Muir Valve

  1. Objective Assessment of Swallowing Function: FEES allows healthcare professionals to directly observe the swallowing process, providing valuable information about the safety and efficiency of swallowing. By incorporating the Passy Muir Valve (PMV) during FEES, clinicians can assess the impact of the valve on swallowing function and make informed decisions regarding decannulation readiness.
  1. Identifying Aspiration and Penetration: FEES enables the detection of aspiration and penetration, which are significant concerns during decannulation. During FEES, the clinician may assess how this reduces aspiration or penetration events. This combined approach allows clinicians to make evidence-based decisions regarding decannulation safety (Escudero et al., 2022).
  1. Assessing Airway Protection: The Passy Muir Valve supports airway protection during swallowing by facilitating glottic closure. The Valve restores more functional cough and throat clear through use of the upper airway and restored pressures (O’Connor et al., 2019). FEES can help assess the effectiveness of the Valve in preventing material from entering the airway during swallowing, ensuring a more safe (protected airway) oral intake.
  1. Determining Timing and Coordination: FEES with the Passy Muir Valve provides insights into the timing and coordination of swallowing. It allows clinicians to evaluate the impact of the valve on the respiratory-swallowing coordination and ensure that the patient can maintain an appropriate breathing pattern during oral feeding (Han et al., 2022).
  1. Gradual Transition to Oral Feeding: The Passy Muir Valve can be used during FEES to assess the patient’s tolerance and readiness for oral feeding. Use of the Valve during swallowing trials as part of the assessment process allows clinicians to observe the impact on swallowing function and determine if the patient can safely tolerate oral feeds. It also assists with identifying if use of the Valve during oral feeding may be necessary for protection of the airway.
Bedside Fiberoptic Endoscopic Evaluation
Used with permission from Passy Muir

Clinical Considerations and Protocol

  1. Collaboration and Multidisciplinary Approach: Successful decannulation and management of swallowing function require collaboration among healthcare professionals, including otolaryngologists, speech-language pathologists, respiratory therapists, and nurses (Mah et al., 2017). Each team member contributes their expertise to ensure comprehensive evaluation and management.
  1. Patient Selection: Careful patient selection is crucial when considering decannulation and utilizing FEES with the Passy Muir Valve. Ideally, candidates should demonstrate stable respiratory status, appropriate cognitive function, and adequate swallowing abilities to ensure safety during the decannulation process. However, some patients may be decannulated who still demonstrate reduced functions.
  1. Step-wise Evaluation: The decannulation process should be approached step-by-step. Considering that the patient’s respiratory and swallowing function are impacted by an open tracheostomy tube, the first place to start is closing the system. This would entail using the Passy Muir Valve to redirect airflow up to the mouth and nose and reengaging the upper airway function. With a closed system, swallowing can then be addressed as the airflow and pressures have been redirected into a more normal pattern. Swallowing assessment, including instrumental assessment with FEES, may be performed at different stages to assess swallowing function with and without the valve, ensuring that the patient can safely tolerate oral feeds. Some patients may not be able to use a speaking valve and then that step may be bypassed. However, if unable to tolerate a Passy Muir Valve, this may be an indication of issues that would negatively impact decannulation (Escudero et al., 2022). 
  1. Objective Assessment Criteria: Specific criteria should be established to determine decannulation readiness based on the FEES findings, Valve use, and patient’s medical status. These criteria may include absence of aspiration or penetration, effective airway protection, appropriate timing and coordination, and safe oral intake with the Passy Muir Valve.
  1. Monitoring and Follow-up: Close monitoring and frequent follow-up are essential throughout the decannulation process. Post-decannulation, assessment of swallowing function should be conducted to ensure long-term safety and successful transition to oral feeding.

Benefits and Impact on Patients

The utilization of FEES with the Passy Muir Valve during the decannulation process offers several benefits for patients:

  1. Enhanced Safety: The combined approach allows clinicians to objectively evaluate swallowing function and make informed decisions regarding decannulation, ensuring the patient’s safety during oral feeding.
  1. Improved Swallowing Function: The Passy Muir Valve supports effective airway protection and promotes optimal swallowing function (Han et al., 2022; O’Connor et al., 2021; O’Connor et al., 2019). By using FEES, clinicians can assess the valve’s impact on swallowing and adjust management strategies accordingly.
  1. Psychological and Quality of Life Benefits: Successful decannulation enhances the patient’s self-esteem, independence, and overall quality of life. The use of FEES with the Passy Muir Valve provides a comprehensive approach that focuses on patients’ long-term well-being and functional outcomes (Freeman-Sanderson et al., 2018).

Conclusion

The combination of FEES with the Passy Muir Valve offers a comprehensive and evidence-based approach to facilitate safe and successful decannulation. By objectively evaluating swallowing function, identifying aspiration risks, and determining the impact of the Passy Muir Valve on swallowing dynamics and respiratory function, healthcare professionals can make informed decisions regarding decannulation readiness. This approach ensures patient safety, promotes optimal swallowing function, and enhances the patient’s overall quality of life post-decannulation. The utilization of FEES with the Passy Muir Valve represents a valuable tool in the management of patients undergoing decannulation, supporting successful transition to safe and effective oral feeding.

References

Christiansen, K. J., Devantier, L., Pasgaard, T., Benson, T. E., Petersen, J. J., Kjærgaard, T., & Pedersen, M. (2022). Tracheostomy healing time after decannulation. Multidisciplinary Respiratory Medicine, 16(1), 822. https://doi.org/10.4081/mrm.2022.822 

Escudero, C., Sassi, F. C., de Medeiros, G. C., de Lima, M. S., Cardoso, P. F. G., & de Andrade, C. R. F. (2022). Decannulation: a retrospective cohort study of clinical and swallowing indicators of success. Clinics (Sao Paulo, Brazil), 77, 100071. https://doi.org/10.1016/j.clinsp.2022.100071 

Freeman-Sanderson, A. L., Togher, L., Elkins, M., & Kenny, B. (2018). Quality of life improves for tracheostomy patients with return of voice: A mixed methods evaluation of the patient experience across the care continuum. Intensive & Critical Care Nursing, 46, 10–16. https://doi.org/10.1016/j.iccn.2018.02.004 

Han, X., Ye, Q., Meng, Z., Pan, D., Wei, X., Wen, H., & Dou, Z. (2022). Biomechanical mechanism of reduced aspiration by the Passy-Muir valve in tracheostomized patients following acquired brain injury: Evidences from subglottic pressure. Frontiers in Neuroscience, 16, 1 – 13. https://doi.org/10.3389/fnins.2022.1004013 

Mah, J. W., Staff, I. I., Fisher, S. R., & Butler, K. L. (2017). Improving decannulation and swallowing function: A comprehensive, multidisciplinary approach to post-tracheostomy care. Respiratory Care, 62(2), 137–143. https://doi.org/10.4187/respcare.04878 

O’Connor, L. R., Morris, N. R., & Paratz, J. (2019). Physiological and clinical outcomes associated with use of one-way speaking valves on tracheostomised patients: A systematic review. Heart & Lung, 48(4), 356-364. https://doi.org/10.1016/j.hrtlng.2018.11.006 

O’Connor, L. R., Morris, N., & Paratz, J. (2021). The safety and efficacy of prolonged use of one-way speaking valves. Australian Critical Care, 34(4), 319-326. https://doi.org/10.1016/j.aucc.2020.09.003 

Starmer, H. M. (2022). Incorporating Flexible Endoscopic Evaluation of Swallowing Rating Scales Into Clinical Practice. Perspectives of the ASHA Special Interest Groups, 1-7.

Zhou, T., Wang, J., Zhang, C., Zhang, B., Guo, H., Yang, B., Li, Q., Ge, J., Li, Y., Niu, G., Gao, H., & Jiang, H. (2022). Tracheostomy decannulation protocol in patients with prolonged tracheostomy referred to a rehabilitation hospital: a prospective cohort study. Journal of Intensive Care, 10, 34, 1 – 9. https://doi.org/10.1186/s40560-022-00626-3 

Share article:TwitterFacebookLinkedin
Airway Aspiration Decannulation Dysphagia FEES Fiberoptic Endoscopic Evaluation Passy Muir Speaking Valve Speech-language pathology Tracheostomy
AboutKristin King, PhD, CCC-SLP
Dr. Kristin King has been a speech-language pathologist in a variety of settings since 1995. She earned her PhD in Communication Sciences and Disorders from East Carolina University in 2008, specializing in cognitive-communication and swallowing disorders with medically complex patients of all ages. She has trained SLPs in FEES and VFSS and developed programs for the management of patients on ventilators and use of the Passy Muir® Valve. She also developed programs for assessment, treatment, and management of patients with TBI. She has published peer-reviewed articles; is a recognized and invited speaker both domestically and internationally on the use of speaking valves, evaluation and treatment following TBI, and swallowing disorders; and has served as an expert witness. She currently conducts research in these areas and maintains clinical skills through consultative services. She also participates in the development of multimedia education on topics relevant to speech-language pathology, respiratory therapy, and nursing, among other clinical professions. She is the Vice President of Clinical Education and Research for Passy Muir.
The Other Side of the Bed-To the Class of 2023

The Other Side of the Bed-To the Class of 2023

June 15, 2023

Multidisciplinary Swallow Clinic: Can I do it too?

September 18, 2023
Multidisciplinary Swallow Clinic: Can I do it too?

Other courses you may enjoy

#ld-cg-ml9i7jftqw .list > .item .content .entry-title, #ld-cg-ml9i7jftqw .list > .item .content .entry-title *{} #ld-cg-ml9i7jftqw .list > .item .content .entry-title{} #ld-cg-ml9i7jftqw .list > .item .content .entry-title *{} #ld-cg-ml9i7jftqw .list > .item .content .entry-content{} #ld-cg-ml9i7jftqw .list > .item .content .entry-content *{} #ld-cg-ml9i7jftqw .list > .item .ribbon{} #ld-cg-ml9i7jftqw .list > .item .ribbon, #ld-cg-ml9i7jftqw .list > .item .ribbon *{} #ld-cg-ml9i7jftqw .list > .item .icon{} #ld-cg-ml9i7jftqw .list > .item .icon, #ld-cg-ml9i7jftqw .list > .item .icon *{} #ld-cg-ml9i7jftqw .list > .item .button, #ld-cg-ml9i7jftqw .list > .item .button *{} #ld-cg-ml9i7jftqw .list > .item .button, #ld-cg-ml9i7jftqw .list > .item .button *{}
Interpreting Oral Phase Signals That Shape Swallow Performance: What Clinicians Need to Know

Interpreting Oral Phase Signals That Shape Swallow Performance: What Clinicians Need to Know

Applying and Integrating Outside the Box Thinking for Chronic Swallowing Disorders in the Outpatient Setting

Applying and Integrating Outside the Box Thinking for Chronic Swallowing Disorders in the Outpatient Setting

Advancing Speech Pathology Care in the Trauma Population

Advancing Speech Pathology Care in the Trauma Population

INDICATIONS AND USAGE:

VARIBAR ® THIN HONEY (barium sulfate) oral suspension, VARIBAR ® NECTAR (barium sulfate) oral suspension, and VARIBAR ® THIN LIQUID (barium sulfate) for oral suspension, are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients. VARIBAR ® HONEY (barium sulfate) oral suspension and VARIBAR ® PUDDING (barium sulfate) oral paste are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients 6 months of age and older.

IMPORTANT SAFETY INFORMATION:
For Oral Administration. This product should not be used in patients with known or suspected perforation of the GI tract, known obstruction of the GI tract, high risk of aspiration, or hypersensitivity to barium sulfate products. Rarely, severe allergic reactions of anaphylactoid nature have been reported following administration of barium sulfate contrast agents. Aspiration may occur during the modified barium swallow examination, monitor the patient for aspiration.

Please consult full Prescribing Information for VARIBAR products by clicking HERE.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit FDA or call 1-800-FDA-1088.

logotype

Dysphagia Café’s mission is to be a quality, consistent, reliable and easily accessible resource and education community for every dysphagia clinician worldwide. This is achieved by generating and promoting original evidence-based content by global leaders in dysphagia research and practice.

Legal links

  • Cancellation and Refunds Policy
  • Terms & condition

Non-Discrimationa Disclosure: Dysphagia Cafe does not discriminate against individuals based on their race, color, ethnicity, religion, sex, national origin, age, disability or genetic information.

Social media

Facebook Linkedin Pinterest X-twitter Youtube Instagram

© Copyright 2013 Dysphagia Cafe All rights reserved.

Login

Lost Your Password?
dysphagia cafe logo
Register
Don't have an account? Register one!
Register an Account

Registration confirmation will be emailed to you.